Matters of Survival
Is better HIV treatment related to improved survival after an individual is diagnosed with an AIDS-defining opportunistic illness (AIDS-OI)? That was one of the...
Undetectable = Untransmittable Reconfirmed by New Study, Embraced at IAS 2017
A newly completed study of 358 serodiscordant gay couples has not found a single case of HIV transmission in 16,889 acts of condomless anal...
Borrowing Therapies
Two Anti-Cancer Drugs Are Tapped in the Fight Against HIV
by Chael Needle
New types of drugs are needed in the fight against HIV but some of...
Verve for VERxVE
An extended release formulation breaks through
by Chael Needle
Based on results from the VERxVE study, the FDA recently approved Viramune XR for use in antiretroviral...
Protecting the Pipeline
LifeGuide
HIV drug development faces challenges
by Jeannie Wraight and Mariel Selbovitz, MPH
Triple and now quad drugs like Gilead’s Atripla and their new compound known...
Restoring Immune Balance
Chronic inflammation means the immune system is imbalanced—a natural immune response has persisted, or immune regulation is not working properly. Research has shown that...
Global HIV and COVID-19 Emergency Response Fund
Global HIV and COVID-19 Emergency Response Fund
On April 27, 2020, ViiV Healthcare announced the creation of £3-million Global HIV and COVID-19 Emergency Response Fund...
Ending Disparities
As the United States Conference on AIDS (USCA 2015) will convene shortly (September 10–13) in Washington, D.C.—and its theme is “The Numbers Don’t Lie:...
TB Announced
A not-for-profit biotech helps energize the future of TB vaccine R&D
by Chael Needle
According to the World Health Organization, tuberculosis is the most common illness...
Early Bird
Study results show immediate treatment holds promise as a prevention tool
by Chael Needle
Treatment and prevention make good bedfellows. That’s the idea underscoring the results...